These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18284542)

  • 1. A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas.
    Søland TM; Husvik C; Koppang HS; Boysen M; Sandvik L; Clausen OP; Christoffersen T; Bryne M
    J Oral Pathol Med; 2008 Oct; 37(9):535-42. PubMed ID: 18284542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
    Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
    Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
    Wang X; Zhang J; Fan M; Zhou Q; Deng H; Aisharif MJ; Chen X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):547-54. PubMed ID: 19327640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
    Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
    Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of activated ERK1/2 and cyclin D1 in oral squamous cell carcinoma].
    Wang LH; Liu TJ; Geng L
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):854-5. PubMed ID: 17416010
    [No Abstract]   [Full Text] [Related]  

  • 7. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
    Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
    Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Takamori K; Igawa K; Yoshida M; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2006 May; 35(5):301-6. PubMed ID: 16630294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
    Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
    Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
    Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear and cytoplasmic expression of Met in oral squamous cell carcinoma and in an organotypic oral cancer model.
    Brusevold IJ; Søland TM; Khuu C; Christoffersen T; Bryne M
    Eur J Oral Sci; 2010 Aug; 118(4):342-9. PubMed ID: 20662906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of TC21 overexpression in oral cancer.
    Macha MA; Matta A; Sriram U; Thakkar A; Shukla NK; Datta Gupta S; Ralhan R
    J Oral Pathol Med; 2010 Jul; 39(6):477-85. PubMed ID: 20040018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent.
    Husvik C; Bryne M; Halstensen TS
    Eur J Oral Sci; 2009 Oct; 117(5):528-35. PubMed ID: 19758248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of nuclear pSTAT3 in oral cancer.
    Macha MA; Matta A; Kaur J; Chauhan SS; Thakar A; Shukla NK; Gupta SD; Ralhan R
    Head Neck; 2011 Apr; 33(4):482-9. PubMed ID: 20652980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
    Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas.
    Tosco P; La Terra Maggiore GM; Forni P; Berrone S; Chiusa L; Garzino-Demo P
    Oral Dis; 2011 Jan; 17(1):102-8. PubMed ID: 20659261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
    Sasahira T; Kirita T; Bhawal UK; Yamamoto K; Ohmori H; Fujii K; Kuniyasu H
    Histopathology; 2007 Aug; 51(2):166-72. PubMed ID: 17593216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.